{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T11:36:30Z","timestamp":1775561790484,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100020225","name":"Universidade de Fortaleza","doi-asserted-by":"publisher","award":["Edital Equipes 61"],"award-info":[{"award-number":["Edital Equipes 61"]}],"id":[{"id":"10.13039\/100020225","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020225","name":"Universidade de Fortaleza","doi-asserted-by":"publisher","award":["Edital Equipes 61"],"award-info":[{"award-number":["Edital Equipes 61"]}],"id":[{"id":"10.13039\/100020225","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020225","name":"Universidade de Fortaleza","doi-asserted-by":"publisher","award":["Edital Equipes 61"],"award-info":[{"award-number":["Edital Equipes 61"]}],"id":[{"id":"10.13039\/100020225","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Retin Vitr"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>Congenital syphilis (CS) is associated with interstitial keratitis, chorioretinitis, uveitis, and optic atrophy mainly in inadequately treated patients. We conducted a retrospective cohort analysis evaluating ocular findings in children born in 2015 with CS treated with ceftriaxone at the time of delivery during the period of penicillin shortage in a city located at Northeast of Brazil and compared them with those adequately treated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>469 children were reported with CS at birth during the penicillin shortage period and 171 were actively searched and invited to an ophthalmological assessment and retrospective analysis of their information recorded in the medical records of the municipality\u2019s health services.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 68 children came to the assessment, median age 8 years of age (range 7\u20138 years), 48 were treated with penicillin (70.5%) and 20 with ceftriaxone (29.5%). There were no significant differences in demographic or perinatal characteristics between the groups. The majority of children had a completely normal ophthalmological examination (67.6%). Regarding findings that are more associated with CS, one child in ceftriaxone group (5.0%) had optic atrophy in one eye and one in the penicillin group (2.9%) had glaucomatous optic disc changes. No interstitial keratitis was found. There was no significant association between the child\u2019s treatment and the prevalence of ophthalmologic findings (<jats:italic>p<\/jats:italic>\u2009=\u20090.663). There was also no association between the medication and a current reactive VDRL (<jats:italic>p<\/jats:italic>\u2009=\u20091.000).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>After an 8-year follow-up, no statistically significant difference was observed in the incidence of ophthalmologic manifestations among individuals treated for CS with either penicillin or ceftriaxone. These findings suggest that ceftriaxone may serve as an effective alternative for the prevention of CS and its associated ocular complications.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s40942-025-00689-y","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T08:48:55Z","timestamp":1749545335000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comparative evaluation of long-term ophthalmic sequelae following first versus second-line antibiotic treatment for congenital syphilis"],"prefix":"10.1186","volume":"11","author":[{"given":"Samuel Montenegro","family":"Pereira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Alix Leite","family":"Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rian Vilar","family":"Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rivianny Arrais","family":"Nobre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Patr\u00edcia Alves","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana F\u00e1tima","family":"Braga Rocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo","family":"Jorge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Broutet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,10]]},"reference":[{"key":"689_CR1","unstructured":"The Global Health Observatory Data on Syphilis [Internet]. World Health Organisation. (2022). Available from: https:\/\/www.who.int\/data\/gho\/data\/themes\/topics\/data-on-syphilis"},{"key":"689_CR2","unstructured":"World Health Organization. Guidance for the elimination of syphilis and congenital syphilis in the Americas [Internet], Washington DC. Pan American Health Organization; 2024 Oct 10 [cited 2025 Mar 28]. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789275127259"},{"issue":"2","key":"689_CR3","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.survophthal.2021.06.003","volume":"67","author":"JM Furtado","year":"2022","unstructured":"Furtado JM, Sim\u00f5es M, Vasconcelos-Santos D, Oliver GF, Tyagi M, Nascimento H, et al. Ocular Syphilis Surv Ophthalmol. 2022;67(2):440\u201362.","journal-title":"Ocular Syphilis Surv Ophthalmol"},{"key":"689_CR4","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1001\/archderm.1937.01470220003001","volume":"35","author":"HN Cole","year":"1937","unstructured":"Cole HN, Usilton LF, Moore JE. Late prenatal syphilis, with special reference to interstitial keratitis: its prevention and treatment. Arch Dermatol Syphilol. 1937;35:563\u201379. https:\/\/doi.org\/10.1001\/archderm.1937.01470220003001.","journal-title":"Arch Dermatol Syphilol"},{"key":"689_CR5","doi-asserted-by":"crossref","unstructured":"Villarreal DD, Le J, Klausner JD. Congenital Syphilis\u2013 Comprehensive narrative review of alternative antibiotic treatment for use in neonates. Sex Transm Dis. 2024.","DOI":"10.1097\/OLQ.0000000000002057"},{"key":"689_CR6","doi-asserted-by":"crossref","unstructured":"Rocha AFB, Ara\u00fajo MAL, Taylor MM, Kara EO, Broutet NJN. Treatment administered to newborns with congenital syphilis during a penicillin shortage in 2015, fortaleza, Brazil. BMC Pediatr. 2021;21(1).","DOI":"10.1186\/s12887-021-02619-x"},{"key":"689_CR7","unstructured":"Cear\u00e1. Secretaria Da Sa\u00fade do Estado do cear\u00e1; cear\u00e1: 2022. Boletim epidemiol\u00f3gico de s\u00edfilis."},{"issue":"12","key":"689_CR8","doi-asserted-by":"publisher","first-page":"e0002626","DOI":"10.1371\/journal.pgph.0002626","volume":"3","author":"M Etti","year":"2023","unstructured":"Etti M, Silva A, Monteiro HS, Alix M, Santos, Castro MC. Determinants of congenital syphilis in fortaleza, brazil: A retrospective case-control study. PLOS Global Public Health. 2023;3(12):e0002626\u20136.","journal-title":"PLOS Global Public Health"},{"issue":"3","key":"689_CR9","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.jped.2022.11.011","volume":"99","author":"AFB Rocha","year":"2023","unstructured":"Rocha AFB, Ara\u00fajo MAL, de Oliveira AKD, de Oliveira LF, Pimentel LDGV, Melo ALL. Follow-up of infants with congenital syphilis during the penicillin shortage period. Jornal De Pediatria. 2023;99(3):302\u20138.","journal-title":"Jornal De Pediatria"},{"issue":"3","key":"689_CR10","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1056\/NEJMra2202762","volume":"390","author":"I Stafford","year":"2024","unstructured":"Stafford I, Workowski KA, Bachmann LH. Syphilis complicating pregnancy and congenital syphilis. N Engl J Med. 2024;390(3):242\u201353.","journal-title":"N Engl J Med"},{"key":"689_CR11","doi-asserted-by":"crossref","unstructured":"Alhawsawi AA, Aljahdali A, Magharbil E, Alzuabi A, Albloushi AF, Alhamad D et al. The clinical spectrum and outcomes of ocular syphilis in Saudi arabia: the emergence of a uveitic masquerader. J Epidemiol Global Health. 2025;15(1).","DOI":"10.1007\/s44197-025-00374-1"},{"key":"689_CR12","doi-asserted-by":"crossref","unstructured":"Bettuzzi T, Jourdes A, Robineau O, Alcaraz I, Manda V, Molina JM et al. Ceftriaxone compared with benzylpenicillin in the treatment of neurosyphilis in france: a retrospective multicentre study. Lancet Infect Dis. 2021;21(10).","DOI":"10.1016\/S1473-3099(20)30857-4"},{"key":"689_CR13","doi-asserted-by":"crossref","unstructured":"Gu X, Lu H, Yang Y, Zhu L, Shi M, Guan Z et al. Could ceftriaxone be a viable alternative to penicillin for the treatment of ocular syphilis? Antimicrob Agents Chemother. 2024.","DOI":"10.1128\/aac.00080-24"},{"issue":"3","key":"689_CR14","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.revmed.2019.06.006","volume":"41","author":"B Gutierrez","year":"2020","unstructured":"Gutierrez B, Gayet S, Bertolino J, Jean E, Le Goff L, Voisin H, et al. La syphilis oculaire, Une pathologie r\u00e9-\u00e9mergente: S\u00e9rie de 12 patients Au CHU de Marseille En 2017. La Revue De M\u00e9decine Interne. 2020;41(3):160\u20137.","journal-title":"La Revue De M\u00e9decine Interne"},{"issue":"10","key":"689_CR15","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1016\/j.jfo.2021.04.017","volume":"44","author":"SL Philippe","year":"2021","unstructured":"Philippe SL, Promelle V, Taright N, Rahmania N, Jany B, Errera MH, et al. La syphilis oculaire, retour d\u2019une maladie oubli\u00e9e: \u00e9tude r\u00e9trospective de 18 Cas diagnostiqu\u00e9s Au CHU d\u2019amiens. J Fran\u00e7ais D Ophtalmologie. 2021;44(10):1566\u201375.","journal-title":"J Fran\u00e7ais D Ophtalmologie"},{"issue":"11","key":"689_CR16","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1007\/s00417-010-1481-z","volume":"248","author":"C Puech","year":"2010","unstructured":"Puech C, St\u00e9phane Gennai, Pavese P, Pelloux I, Maurin M, Romanet J-P, et al. Ocular manifestations of syphilis: recent cases over a 2.5-year period. Graefe S Archive Clin Experimental Ophthalmol. 2010;248(11):1623\u20139.","journal-title":"Graefe S Archive Clin Experimental Ophthalmol"},{"issue":"6","key":"689_CR17","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1097\/OLQ.0000000000001329","volume":"48","author":"LF Wagner","year":"2020","unstructured":"Wagner LF, Lanzl I, Rothe K, Schneider J, Zink A, Zapp D, et al. Clinical and ophthalmological characteristics of ocular syphilis in a retrospective tertiary hospital cohort. Sex Transm Dis. 2020;48(6):436\u201342.","journal-title":"Sex Transm Dis"},{"issue":"12","key":"689_CR18","doi-asserted-by":"publisher","first-page":"e328","DOI":"10.1097\/INF.0000000000001576","volume":"36","author":"EM Molyneux","year":"2017","unstructured":"Molyneux EM, Dube Q, Banda FM, Chiume M, Singini I, Mallewa M, et al. The treatment of possible severe infection in infants. Pediatr Infect Disease J. 2017;36(12):e328\u201333.","journal-title":"Pediatr Infect Disease J"}],"container-title":["International Journal of Retina and Vitreous"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-025-00689-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40942-025-00689-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-025-00689-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T08:48:59Z","timestamp":1749545339000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalretinavitreous.biomedcentral.com\/articles\/10.1186\/s40942-025-00689-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,10]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["689"],"URL":"https:\/\/doi.org\/10.1186\/s40942-025-00689-y","relation":{},"ISSN":["2056-9920"],"issn-type":[{"value":"2056-9920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,10]]},"assertion":[{"value":"26 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the institutional review board under the protocol number 2.110.189 on 04\/10\/2023. The municipal health department provided a letter of consent for the use of the information. All legal parents or guardians and children have signed an informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"63"}}